CAPSTONE INVESTMENT ADVISORS, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,300,000
-25.3%
2,500,000
-28.6%
0.01%
-33.3%
Q2 2023$1,739,150
+23.9%
3,500,0000.0%0.01%
+28.6%
Q1 2023$1,403,850
-27.1%
3,500,0000.0%0.01%
-50.0%
Q4 2022$1,925,000
-2.3%
3,500,0000.0%0.01%
+16.7%
Q3 2022$1,971,000
+1.7%
3,500,0000.0%0.01%
+33.3%
Q2 2022$1,938,000
+7.4%
3,500,0000.0%0.01%
+80.0%
Q1 2022$1,805,000
-2.2%
3,500,0000.0%0.01%
+66.7%
Q4 2021$1,846,0003,500,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2021
NameSharesValueWeighting ↓
Context Capital Management, LLC 18,764$9,907,0000.77%
Pentwater Capital Management LP 46,411,000$24,770,0000.27%
WHITEBOX ADVISORS LLC 22,500,000$11,756,0000.24%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$10,993,0000.23%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 17,590,000$9,286,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$12,540,0000.18%
BlueCrest Capital Management Ltd 7,000,000$3,705,0000.12%
DCF Advisers, LLC 400,000$211,0000.09%
Walleye Capital LLC 5,000$2,638,0000.08%
INGALLS & SNYDER LLC 883,000$461,0000.02%
View complete list of ESPERION THERAPEUTICS INC NE shareholders